Novel and emerging therapies for asthma

作者: Thomas M. Leath , Manav Singla , Stephen P. Peters

DOI: 10.1016/S1359-6446(05)03646-9

关键词:

摘要: At present, there are a wide variety of novel and emerging therapeutic approaches for the treatment asthma. Here, we will summarize these state-of-the-art approaches, including specific nonspecific mediator inhibition – quest that has been on going more than 25 years together with cytokine modulation in asthma (primarily attempting to modulate Th2–Th1 balance asthma), targeting cell recruitment, angiogenesis, signal transduction gene pathways. Finally, discuss recently approved anti-IgE therapy allergic immune using CpG oligodeoxynucleotides.

参考文章(104)
Ulf Forssmann, Inka Hartung, Ralf Bälder, Barbara Fuchs, Sylvia E. Escher, Nikolaj Spodsberg, Yasmin Dulkys, Michael Walden, Aleksandra Heitland, Armin Braun, Wolf-Georg Forssmann, Jörn Elsner, n-Nonanoyl-CC chemokine ligand 14, a potent CC chemokine ligand 14 analogue that prevents the recruitment of eosinophils in allergic airway inflammation Journal of Immunology. ,vol. 173, pp. 3456- 3466 ,(2004) , 10.4049/JIMMUNOL.173.5.3456
Nicholas W. Lukacs, Allison L. Miller, Cory M. Hogaboam, Chemokine receptors in asthma: searching for the correct immune targets. Journal of Immunology. ,vol. 171, pp. 11- 15 ,(2003) , 10.4049/JIMMUNOL.171.1.11
LARRY C. BORISH, HAROLD S. NELSON, MIGUEL J. LANZ, LORI CLAUSSEN, JAMES B. WHITMORE, JAN M. AGOSTI, LESLIE GARRISON, Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. American Journal of Respiratory and Critical Care Medicine. ,vol. 160, pp. 1816- 1823 ,(1999) , 10.1164/AJRCCM.160.6.9808146
Christophe Desmet, Philippe Gosset, Bernard Pajak, Didier Cataldo, Mohamed Bentires-Alj, Pierre Lekeux, Fabrice Bureau, Selective Blockade of NF-κB Activity in Airway Immune Cells Inhibits the Effector Phase of Experimental Asthma Journal of Immunology. ,vol. 173, pp. 5766- 5775 ,(2004) , 10.4049/JIMMUNOL.173.9.5766
M FUJIMURA, S SAKAMOTO, M SAITO, Y MIYAKE, T MATSUDA, Effect of a thromboxane A2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthma. The Journal of Allergy and Clinical Immunology. ,vol. 87, pp. 23- 27 ,(1991) , 10.1016/0091-6749(91)90208-6
M. Solèr, J. Matz, R. Townley, R. Buhl, J. O'brien, H. Fox, J. Thirlwell, N. Gupta, G. Della Cioppa, The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics European Respiratory Journal. ,vol. 18, pp. 254- 261 ,(2001) , 10.1183/09031936.01.00092101
Domenico Spina, Theophylline and PDE4 inhibitors in asthma Current Opinion in Pulmonary Medicine. ,vol. 9, pp. 57- 64 ,(2003) , 10.1097/00063198-200301000-00010
Margaret J Leckie, Anneke ten Brinke, Jamey Khan, Zuzana Diamant, Brian J O'connor, Christine M Walls, Ashwini K Mathur, Hugh C Cowley, K Fan Chung, Ratko Djukanovic, Trevor T Hansel, Stephen T Holgate, Peter J Sterk, Peter J Barnes, None, Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response The Lancet. ,vol. 356, pp. 2144- 2148 ,(2000) , 10.1016/S0140-6736(00)03496-6
Larry Borish, Genetics of allergy and asthma Annals of Allergy, Asthma & Immunology. ,vol. 82, pp. 413- 426 ,(1999) , 10.1016/S1081-1206(10)62715-9
Jan Svensson, Kjell Strandberg, Torsten Tuvemo, Mats Hamberg, Thromboxane A2: Effects of airway and vascular smooth muscle Prostaglandins. ,vol. 14, pp. 425- 436 ,(1977) , 10.1016/0090-6980(77)90258-1